WallStSmart

Coursera Inc (COUR)vsCovista Inc. (CVSA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 147% more annual revenue ($1.91B vs $773.90M). CVSA leads profitability with a 12.3% profit margin vs -8.2%. CVSA earns a higher WallStSmart Score of 56/100 (C).

COUR

Avoid

33

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 6.7Quality: 5.8
Piotroski: 5/9Altman Z: 1.03

CVSA

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 7.5Value: 6.3Quality: 6.5
Piotroski: 6/9Altman Z: 3.09
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

COURUndervalued (+33.1%)

Margin of Safety

+33.1%

Fair Value

$8.58

Current Price

$5.47

$3.11 discount

UndervaluedFair: $8.58Overvalued

Intrinsic value data unavailable for CVSA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COUR1 strengths · Avg: 10.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

CVSA3 strengths · Avg: 8.7/10
Altman Z-ScoreHealth
3.0910/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.888/10

Growing faster than its price suggests

Price/BookValuation
3.0x8/10

Reasonable price relative to book value

Areas to Watch

COUR4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.53B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-10.1%2/10

ROE of -10.1% — below average capital efficiency

Altman Z-ScoreHealth
1.032/10

Distress zone — elevated risk

CVSA2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

EPS GrowthGrowth
-24.6%2/10

Earnings declined 24.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : COUR

The strongest argument for COUR centers on Price/Book.

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, Price/Book. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bear Case : COUR

The primary concerns for COUR are EPS Growth, Market Cap, Return on Equity.

Bear Case : CVSA

The primary concerns for CVSA are Revenue Growth, EPS Growth.

Key Dynamics to Monitor

COUR profiles as a turnaround stock while CVSA is a value play — different risk/reward profiles.

COUR carries more volatility with a beta of 1.25 — expect wider price swings.

COUR is growing revenue faster at 9.1% — sustainability is the question.

CVSA generates stronger free cash flow (166M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (56/100 vs 33/100). COUR offers better value entry with a 33.1% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coursera Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Coursera, Inc. operates an online educational content platform that connects students, educators, and institutions. The company is headquartered in Mountain View, California.

Visit Website →

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?